Introduction: recent progress in therapy of prostatic carcinoma and other hormone dependent pathology with the use of agonistic analogs of LHRH
Bertelli, A.
Drugs under Experimental and Clinical Research 16(Suppl): 1-2
1990
ISSN/ISBN: 0378-6501 PMID: 2081448 Document Number: 354892
Document emailed within 1 workday
Related Documents
Wilking, N.; Rutqvist, L.E.; Theve, T. 1988: LHRH analogs--a new treatment in hormone-dependent tumors Lakartidningen 85(8): 620-623Thau, R.B. 1984: Luteinizing hormone-releasing hormone (LHRH) and its analogs for contraception in women: a review Contraception 29(2): 143-162
Kuber, W.; Treu, T.; Kratzik, C.; Girsch, E.; Zeillinger, R.; Spona, J. 1990: Chemical castration using a depot LHRH-agonist as a palliative therapy concept in prostatic carcinoma--clinical, endocrinological and experimental studies Wiener Klinische Wochenschrift 102(21): 640-647
Rubio Herrera, M.A.; Calle Fernández, J.R. 1986: Treatment of carcinoma of the prostate with analogs of LHRH Revista Clinica Espanola 179(8): 407-411
Singh, V. 1992: Immunospecificity and affinity studies on anti-luteinizing hormone releasing hormone antibodies developed by azo-LHRH-TT and azo-LHRH-BSA conjugates Biochemistry International 27(4): 591-599
Klosterhalfen, H. 1977: Hormone therapy of prostatic carcinoma Deutsche Medizinische Wochenschrift 102(25): 947
Studer, U.E. 1995: Advanced prostatic carcinoma--which hormone therapy when? Der Urologe. Ausg. a 34(5): 361-366
Dondi, D.; Limonta, P.; Moretti, R.M.; Marelli, M.M.; Garattini, E.; Motta, M. 1994: Antiproliferative effects of luteinizing hormone-releasing hormone (LHRH) agonists on human androgen-independent prostate cancer cell line DU 145: evidence for an autocrine-inhibitory LHRH loop Cancer Research 54(15): 4091-4095
Zhu, B.; Chu, Y.; Chu, J.; Liu, Y. 1990: The direct effects of lhrh and three lhrh analogs on progesterone secretion by early pregnant human luteal cells in vitro Journal of Shanghai Medical University 17(1): 11-14
Ebert, T.; Bendhack, M.L. 1997: Prostatic carcinoma--diagnosis, hormone therapy, radio- and chemotherapy Der Urologe. Ausg. a 36(6): 570-577
Korczak, D.; Golomb, J.; Siegel, Y.; Lindner, A. 1988: Treatment of advanced prostatic carcinoma with LHRH analogue Harefuah 115(5-6): 109-111
Kumamoto, Y.; Tsukamoto, T.; Umehara, T.; Harada, M.; Shimazaki, J.; Fuse, H.; Oshima, H.; Takeuchi, H.; Yoshida, O.; Okada, K. 1990: Clinical studies on endocrine therapy of prostatic carcinoma (3): Histopathological features of prostatic carcinoma and its prognosis Hinyokika Kiyo. Acta Urologica Japonica 36(3): 295-305
Gez, E.; Ben-Yosef, R.; Libson, E.; Biran, S. 1987: The use of agonist analogues of luteinizing hormone--releasing hormone in the treatment of prostatic carcinoma Harefuah 112(5): 239-241
St-Arnaud, R.; Lachance, R.; Dupont, A.; Labrie, F. 1986: Stimulation of the circulating levels of glycoprotein hormone alpha-subunit after combined administration of a luteinizing hormone-releasing hormone (LHRH) agonist and flutamide in patients with cancer of the prostate Clinical and Investigative Medicine. Medecine Clinique et Experimentale 9(4): 215-221
Strohmenger, P. 1980: Prostatic adenoma--prostatic carcinoma. Questions from general practice. II. Therapy Zfa. Zeitschrift für Allgemeinmedizin 56(28): 1793-1797
Baranowska, B. 1984: Clinical use of LHRH analogs Polski Tygodnik Lekarski 39(29-30): 1005-1007
Keizman, D.; Eisenberger, M.A. 2009: LHRH antagonists vs LHRH agonists: which is more beneficial in prostate cancer therapy? Oncology 23(7): 631-632
Smals, A.G. 1985: Clinical significance of LHRH and its analogs Nederlands Tijdschrift Voor Geneeskunde 129(1): 15-20
Balmaceda, J.P.; Borrero, C.; Asch, R.H. 1987: Lhrh analogs female contraception Seminars in Reproductive Endocrinology 5(4): 371-380
Soong, Y.K. 1987: Pulsatile administration of luteinizing hormone releasing hormone (LHRH) for inducing ovulation Journal of the Formosan Medical Association 86(10): 1042-1048